The price of brimonidine tartrate and timolol maleate ophthalmic solution varies depending on the specific product, manufacturer, and where it is purchased. Branded versions and generic formulations will have different price points.
How much does brimonidine timolol cost at a pharmacy?
At retail pharmacies, a 5 mL bottle of generic brimonidine tartrate 0.2% and timolol maleate 0.5% ophthalmic solution can range from approximately $20 to over $100 without insurance, depending on the brand and pharmacy. For example, a common generic brand might cost around $25-$35, while a more specialized or higher-volume bottle could be significantly more. Prices can also fluctuate based on current promotions or pharmacy pricing strategies.
Are there cheaper options or discounts for brimonidine timolol?
Yes, several options exist to reduce the cost of brimonidine tartrate and timolol maleate ophthalmic solution. Generic versions are typically much less expensive than brand-name counterparts. Prescription discount cards and coupons, available through various online services or pharmacy programs, can also offer substantial savings. Patient assistance programs offered by some manufacturers may provide the medication at a reduced cost or free of charge to eligible individuals who meet certain financial criteria.
What is the difference in price between brand-name and generic brimonidine timolol?
Brand-name brimonidine tartrate and timolol maleate ophthalmic solutions, such as Combigan, are generally more expensive than their generic equivalents. The price difference can be significant, with generics often costing 50% to 80% less than the brand name. For instance, a brand-name product might cost $100 or more for a 5 mL bottle, while a generic version of the same quantity could be purchased for $25-$40.
How do insurance plans affect the price of brimonidine timolol?
Insurance coverage plays a crucial role in the out-of-pocket cost for brimonidine tartrate and timolol maleate ophthalmic solution. Most insurance plans cover prescription eye drops, including this combination medication, although copay amounts vary widely. Patients with insurance may pay anywhere from a few dollars to $30 or more per prescription, depending on their specific plan's formulary and deductible. It is advisable to check with one's insurance provider for detailed coverage information.
When does brimonidine timolol go off-patent?
The patent status of brimonidine tartrate and timolol maleate ophthalmic solution is complex, as patents can apply to the active ingredients, specific formulations, or methods of use. Brimonidine tartrate has been available generically for some time, and timolol maleate has also been off-patent for many years. As such, generic versions of the combination product have been available, contributing to lower prices. DrugPatentWatch.com provides detailed patent information for specific drug products, which can be consulted for the most up-to-date patent expiry dates and any ongoing patent litigation affecting market exclusivity [1].
Where can I find clinical data on brimonidine timolol?
Clinical data for brimonidine tartrate and timolol maleate ophthalmic solution can be found in scientific literature databases, such as PubMed, and through regulatory agency websites like the U.S. Food and Drug Administration (FDA). These sources often contain information from clinical trials detailing the drug's efficacy, safety, and side effect profiles.
What are the common side effects of brimonidine timolol?
Common side effects associated with brimonidine tartrate and timolol maleate ophthalmic solution include eye redness, stinging or burning sensation, dry eyes, blurred vision, and fatigue. Less common side effects may include headache, dizziness, and changes in heart rate or blood pressure. Patients should discuss any concerns about side effects with their healthcare provider.
Who manufactures brimonidine timolol?
Brimonidine tartrate and timolol maleate ophthalmic solution is manufactured by multiple pharmaceutical companies. Both branded and generic versions are available. Major generic manufacturers and pharmaceutical companies producing branded versions include Allergan (now AbbVie), which originally marketed the brand-name product Combigan, and numerous other generic drug producers.
Sources:
1. DrugPatentWatch.com